Smith, Moore & Co’s Xylem XYL Stock Holding History

Smith, Moore & Co’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-7,746	Closed	-$268K	–	151
2013 Q4	$268K	Buy	+7,746	New	+$249K	0.17%	113

Other funds holding XYL

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Sasco Capital Fairfield, Connecticut $668M AUM 12.79% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return

Smith, Moore & Co's XYL Position: Q1 2014 in Review

Smith, Moore & Co sold out of Xylem (XYL) in Q1 2014, closing a stake of 7,746 shares — an estimated $268K sold.

Smith, Moore & Co first reported a position in XYL in Q4 2013 and held it in 1 quarter. The position peaked at $268K in Q4 2013. 439 funds tracked by Wall St. Rank hold XYL as of Q1 2014.

Smith, Moore & Co reported no remaining Xylem position as of Q1 2014 after selling out during the quarter.
Smith, Moore & Co sold 7,746 Xylem shares in Q1 2014, an estimated $268K.
Smith, Moore & Co first reported a position in Xylem in Q4 2013 and held it in 1 quarter.
Smith, Moore & Co's Xylem position peaked at $268K in Q4 2013.
439 funds tracked by Wall St. Rank held Xylem as of Q1 2014.

Based on Smith, Moore & Co's 13F filing for Q1 2014, filed 1 May 2014.